Canada Life’s Evolent Health EVH Stock Holding History

Canada Life’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,143	Closed	-$40K	–	1852
2025 Q4	$40K	Sell	10,143 -20,324	-67%	-$113K	﹤0.01%	1805
2025 Q3	$267K	Hold	30,467	–	–	﹤0.01%	1673
2025 Q2	$344K	Hold	30,467	–	–	﹤0.01%	1661
2025 Q1	$289K	Hold	30,467	–	–	﹤0.01%	1689
2024 Q4	$342K	Hold	30,467	–	–	﹤0.01%	1695
2024 Q3	$864K	Hold	30,467	–	–	﹤0.01%	1546
2024 Q2	$582K	Sell	30,467 -9,055	-23%	-$231K	﹤0.01%	1647
2024 Q1	$1.3M	Buy	39,522 +3,064	+8%	+$97.8K	﹤0.01%	1425
2023 Q4	$1.2M	Buy	36,458 +3,505	+11%	+$99.2K	﹤0.01%	1449
2023 Q3	$897K	Buy	32,953 +7,460	+29%	+$207K	﹤0.01%	1522
2023 Q2	$777K	Buy	25,493 +5,066	+25%	+$164K	﹤0.01%	1565
2023 Q1	$664K	Hold	20,427	–	–	﹤0.01%	1623
2022 Q4	$577K	Buy	20,427 +8,010	+65%	+$230K	﹤0.01%	1681
2022 Q3	$446K	Buy	12,417 +8,402	+209%	+$296K	﹤0.01%	1704
2022 Q2	$124K	Sell	4,015 -630	-14%	-$18.4K	﹤0.01%	1887
2022 Q1	$160K	Hold	4,645	–	–	﹤0.01%	1914
2021 Q4	$128K	Hold	4,645	–	–	﹤0.01%	1957
2021 Q3	$145K	Hold	4,645	–	–	﹤0.01%	1979
2021 Q2	$98K	Hold	4,645	–	–	﹤0.01%	2090
2021 Q1	$93K	Hold	4,645	–	–	﹤0.01%	2118
2020 Q4	$74K	Hold	4,645	–	–	﹤0.01%	2173
2020 Q3	$58K	Hold	4,645	–	–	﹤0.01%	2144
2020 Q2	$33K	Hold	4,645	–	–	﹤0.01%	2365
2020 Q1	$25K	Hold	4,645	–	–	﹤0.01%	2329
2019 Q4	$42K	Hold	4,645	–	–	﹤0.01%	2319
2019 Q3	$33K	Sell	4,645 -4,109	-47%	-$29.5K	﹤0.01%	1057
2019 Q2	$69K	Hold	8,754	–	–	﹤0.01%	2340
2019 Q1	$110K	Buy	8,754 +2,604	+42%	+$41.2K	﹤0.01%	2043
2018 Q4	$118K	Hold	6,150	–	–	﹤0.01%	2090
2018 Q3	$175K	Hold	6,150	–	–	﹤0.01%	2024
2018 Q2	$130K	Hold	6,150	–	–	﹤0.01%	2107
2018 Q1	$88K	Hold	6,150	–	–	﹤0.01%	2202
2017 Q4	$75K	Hold	6,150	–	–	﹤0.01%	2258
2017 Q3	$112K	Buy	6,150 +2,406	+64%	+$49.6K	﹤0.01%	2115
2017 Q2	$95K	Hold	3,744	–	–	﹤0.01%	2138
2017 Q1	$83K	Hold	3,744	–	–	﹤0.01%	2166
2016 Q4	$56K	Hold	3,744	–	–	﹤0.01%	2292
2016 Q3	$92K	Buy	+3,744	New	+$87.5K	﹤0.01%	2166

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Life's EVH Position: Q1 2026 in Review

Canada Life sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 10,143 shares — an estimated $40K sold.

Canada Life first reported a position in EVH in Q3 2016 and held it in 38 quarters. The position peaked at $1.3M in Q1 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Canada Life reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
Canada Life sold 10,143 Evolent Health shares in Q1 2026, an estimated $40K.
Canada Life first reported a position in Evolent Health in Q3 2016 and held it in 38 quarters.
Canada Life's Evolent Health position peaked at $1.3M in Q1 2024.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.